Literature DB >> 19596784

Arginine methylation regulates telomere length and stability.

Taylor R H Mitchell1, Kimberly Glenfield, Kajaparan Jeyanthan, Xu-Dong Zhu.   

Abstract

TRF2, a component of the shelterin complex, functions to protect telomeres. TRF2 contains an N-terminal basic domain rich in glycines and arginines, similar to the GAR motif that is methylated by protein arginine methyltransferases. However, whether arginine methylation regulates TRF2 function has not been determined. Here we report that amino acid substitutions of arginines with lysines in the basic domain of TRF2 induce telomere dysfunction-induced focus formation, leading to induction of cellular senescence. We have demonstrated that cells overexpressing TRF2 lysine mutants accumulate telomere doublets, indicative of telomere instability. We uncovered that TRF2 interacts with PRMT1, and its arginines in the basic domain undergo PRMT1-mediated methylation both in vitro and in vivo. We have shown that loss of PRMT1 induces growth arrest in normal human cells but has no effect on cell proliferation in cancer cells, suggesting that PRMT1 may control cell proliferation in a cell type-specific manner. We found that depletion of PRMT1 in normal human cells results in accumulation of telomere doublets, indistinguishable from overexpression of TRF2 lysine mutants. PRMT1 knockdown in cancer cells upregulates TRF2 association with telomeres, promoting telomere shortening. Taken together, these results suggest that PRMT1 may control telomere length and stability in part through TRF2 methylation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19596784      PMCID: PMC2738278          DOI: 10.1128/MCB.00009-09

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  66 in total

1.  ERCC1/XPF removes the 3' overhang from uncapped telomeres and represses formation of telomeric DNA-containing double minute chromosomes.

Authors:  Xu-Dong Zhu; Laura Niedernhofer; Bernhard Kuster; Matthias Mann; Jan H J Hoeijmakers; Titia de Lange
Journal:  Mol Cell       Date:  2003-12       Impact factor: 17.970

2.  Ordered cooperative functions of PRMT1, p300, and CARM1 in transcriptional activation by p53.

Authors:  Woojin An; Jaehoon Kim; Robert G Roeder
Journal:  Cell       Date:  2004-06-11       Impact factor: 41.582

Review 3.  Interplay between chromatin remodelers and protein arginine methyltransferases.

Authors:  Sharmistha Pal; Saïd Sif
Journal:  J Cell Physiol       Date:  2007-11       Impact factor: 6.384

4.  Homologous recombination generates T-loop-sized deletions at human telomeres.

Authors:  Richard C Wang; Agata Smogorzewska; Titia de Lange
Journal:  Cell       Date:  2004-10-29       Impact factor: 41.582

5.  Arginine methylation of the human immunodeficiency virus type 1 Tat protein by PRMT6 negatively affects Tat Interactions with both cyclin T1 and the Tat transactivation region.

Authors:  Baode Xie; Cédric F Invernizzi; Stéphane Richard; Mark A Wainberg
Journal:  J Virol       Date:  2007-01-31       Impact factor: 5.103

6.  The mammalian immediate-early TIS21 protein and the leukemia-associated BTG1 protein interact with a protein-arginine N-methyltransferase.

Authors:  W J Lin; J D Gary; M C Yang; S Clarke; H R Herschman
Journal:  J Biol Chem       Date:  1996-06-21       Impact factor: 5.157

7.  Peptides with sequences similar to glycine, arginine-rich motifs in proteins interacting with RNA are efficiently recognized by methyltransferase(s) modifying arginine in numerous proteins.

Authors:  J Najbauer; B A Johnson; A L Young; D W Aswad
Journal:  J Biol Chem       Date:  1993-05-15       Impact factor: 5.157

8.  Mining biomarkers in human sera using proteomic tools.

Authors:  Rulin Zhang; Lisa Barker; Deborah Pinchev; John Marshall; Michèle Rasamoelisolo; Chris Smith; Peter Kupchak; Inga Kireeva; Leslee Ingratta; George Jackowski
Journal:  Proteomics       Date:  2004-01       Impact factor: 3.984

9.  A proteomic analysis of arginine-methylated protein complexes.

Authors:  François-Michel Boisvert; Jocelyn Côté; Marie-Chloé Boulanger; Stéphane Richard
Journal:  Mol Cell Proteomics       Date:  2003-10-07       Impact factor: 5.911

10.  PRMT7 is a member of the protein arginine methyltransferase family with a distinct substrate specificity.

Authors:  Tina Branscombe Miranda; Mark Miranda; Adam Frankel; Steven Clarke
Journal:  J Biol Chem       Date:  2004-03-24       Impact factor: 5.157

View more
  35 in total

1.  TRIP6 and LPP, but not Zyxin, are present at a subset of telomeres in human cells.

Authors:  Samantha A Sheppard; Tatiana Savinova; Diego Loayza
Journal:  Cell Cycle       Date:  2011-06-01       Impact factor: 4.534

Review 2.  Inhibitors of Protein Methyltransferases and Demethylases.

Authors:  H Ümit Kaniskan; Michael L Martini; Jian Jin
Journal:  Chem Rev       Date:  2017-03-24       Impact factor: 60.622

Review 3.  Shelterin complex and associated factors at human telomeres.

Authors:  Raffaella Diotti; Diego Loayza
Journal:  Nucleus       Date:  2011 Mar-Apr       Impact factor: 4.197

4.  Nuclear PRMT1 expression is associated with poor prognosis and chemosensitivity in gastric cancer patients.

Authors:  Bolag Altan; Takehiko Yokobori; Munenori Ide; Erito Mochiki; Yoshitaka Toyomasu; Norimichi Kogure; Akiharu Kimura; Keigo Hara; Tuya Bai; Pinjie Bao; Masaki Suzuki; Kyoichi Ogata; Takayuki Asao; Masahiko Nishiyama; Tetsunari Oyama; Hiroyuki Kuwano
Journal:  Gastric Cancer       Date:  2015-10-15       Impact factor: 7.370

Review 5.  Role of PRMTs in cancer: Could minor isoforms be leaving a mark?

Authors:  R Mitchell Baldwin; Alan Morettin; Jocelyn Côté
Journal:  World J Biol Chem       Date:  2014-05-26

6.  Cockayne syndrome group B protein regulates DNA double-strand break repair and checkpoint activation.

Authors:  Nicole L Batenburg; Elizabeth L Thompson; Eric A Hendrickson; Xu-Dong Zhu
Journal:  EMBO J       Date:  2015-03-27       Impact factor: 11.598

Review 7.  Protein arginine methyltransferases and cancer.

Authors:  Yanzhong Yang; Mark T Bedford
Journal:  Nat Rev Cancer       Date:  2012-12-13       Impact factor: 60.716

Review 8.  Recent advances in targeting protein arginine methyltransferase enzymes in cancer therapy.

Authors:  Emily Smith; Wei Zhou; Polina Shindiapina; Said Sif; Chenglong Li; Robert A Baiocchi
Journal:  Expert Opin Ther Targets       Date:  2018-05-21       Impact factor: 6.902

9.  The basic N-terminal domain of TRF2 limits recombination endonuclease action at human telomeres.

Authors:  Adélaïde Saint-Léger; Melanie Koelblen; Livia Civitelli; Amadou Bah; Nadir Djerbi; Marie-Josèphe Giraud-Panis; Arturo Londoño-Vallejo; Fiorentina Ascenzioni; Eric Gilson
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 10.  The long and the short of TRF2 in neurogenesis.

Authors:  Ioannis Grammatikakis; Peisu Zhang; Mark P Mattson; Myriam Gorospe
Journal:  Cell Cycle       Date:  2016-08-26       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.